Imaging Biomarkers for Predicting Response to Hormonal Therapy in Breast Cancer: A Systematic Review
Current Radiology Reports · 27.07.2026 · 14 (1)
DOI: 10.1007/s40134-026-00440-x ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Current Radiology Reports, online erschienen am 27.07.2026. Verfasst von Kaya L. Russell und 3 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose of Review This systematic review aims to evaluate the timing, mechanism, and clinical implications associated with imaging biomarkers as a method of predicting breast cancer response to hormonal therapy. Recent Findings Current methods of predicting breast cancer response to hormonal therapy are invasive and not representative of the entire tumor. Imaging biomarkers are emerging as a new, non-invasive, reproducible method to predict breast cancer response to hormonal therapy. Summary A comprehensive literature search was conducted on August 22, 2025, using PubMed, Cochrane Library, Web of Science, and Virtual Health Library (VHL). Articles were screened based on inclusion and exclusion criteria. Irrelevant studies were excluded, and the remaining articles proceeded to full-text evaluation, followed by data extraction, quality of reporting assessment, and risk of bias assessment. Fifteen articles were included in this review, all published between 2009 and 2024. For PET/CT scans, the biomarkers utilized were 18-FDG, 18 F-FES, 18 F-FDHT, and 18 F-FMISO. For MRI, contralateral breast parenchymal enhancement and background parenchymal enhancement were considered. The reported strength of the imaging biomarkers to predict response to hormonal therapy varies by the biomarker; however, many of the results are preliminary and require further study to accurately determine their strength. Imaging biomarkers have the potential to guide clinical judgment by determining effective treatments for a patient at an earlier stage in their disease course. This can decrease ineffective treatment, benefitting patients physically, mentally, emotionally, and financially, as well as decreasing healthcare costs.
Zitieren
APA
Russell, K. L., Whaley, A. K., Elsayed, A. A. R., & Basson, M. D. (2026). Imaging Biomarkers for Predicting Response to Hormonal Therapy in Breast Cancer: A Systematic Review. Current Radiology Reports, 14(1). https://doi.org/10.1007/s40134-026-00440-x
Vancouver
Russell KL, Whaley AK, Elsayed AAR, Basson MD. Imaging Biomarkers for Predicting Response to Hormonal Therapy in Breast Cancer: A Systematic Review. Current Radiology Reports. 2026;14(1). doi:10.1007/s40134-026-00440-x
BibTeX
@article{Russell2026,
author = {Russell, Kaya L. and Whaley, Adeline K. and Elsayed, Ahmed Adham R. and Basson, Marc D.},
title = {Imaging Biomarkers for Predicting Response to Hormonal Therapy in Breast Cancer: A Systematic Review},
journal = {Current Radiology Reports},
year = {2026},
volume = {14},
number = {1},
doi = {10.1007/s40134-026-00440-x}
}
EUVIMED